annual total liabilities:
$535.05M-$53.05M(-9.02%)Summary
- As of today (July 1, 2025), TVTX annual total liabilities is $535.05 million, with the most recent change of -$53.05 million (-9.02%) on December 31, 2024.
- During the last 3 years, TVTX annual total liabilities has risen by +$60.53 million (+12.76%).
- TVTX annual total liabilities is now -15.04% below its all-time high of $629.73 million, reached on December 31, 2022.
Performance
TVTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$515.98M-$19.07M(-3.56%)Summary
- As of today (July 1, 2025), TVTX quarterly total liabilities is $515.98 million, with the most recent change of -$19.07 million (-3.56%) on March 31, 2025.
- Over the past year, TVTX quarterly total liabilities has dropped by -$73.50 million (-12.47%).
- TVTX quarterly total liabilities is now -18.06% below its all-time high of $629.73 million, reached on December 31, 2022.
Performance
TVTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TVTX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | -12.5% |
| 3 y3 years | +12.8% | -16.8% |
| 5 y5 years | +39.5% | +48.6% |
TVTX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.0% | +12.8% | -18.1% | at low |
| 5 y | 5-year | -15.0% | +39.5% | -18.1% | +43.3% |
| alltime | all time | -15.0% | >+9999.0% | -18.1% | >+9999.0% |
TVTX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $515.98M(-3.6%) |
| Dec 2024 | $535.05M(-9.0%) | $535.05M(+0.0%) |
| Sep 2024 | - | $534.86M(-0.2%) |
| Jun 2024 | - | $535.97M(-9.1%) |
| Mar 2024 | - | $589.48M(+0.2%) |
| Dec 2023 | $588.10M(-6.6%) | $588.10M(+6.3%) |
| Sep 2023 | - | $553.08M(-10.8%) |
| Jun 2023 | - | $619.94M(+0.1%) |
| Mar 2023 | - | $619.09M(-1.7%) |
| Dec 2022 | $629.73M(+32.7%) | $629.73M(+0.7%) |
| Sep 2022 | - | $625.54M(+0.4%) |
| Jun 2022 | - | $622.78M(+0.4%) |
| Mar 2022 | - | $620.26M(+30.7%) |
| Dec 2021 | $474.52M(+19.8%) | $474.52M(+1.5%) |
| Sep 2021 | - | $467.70M(+12.8%) |
| Jun 2021 | - | $414.46M(+3.3%) |
| Mar 2021 | - | $401.36M(+1.3%) |
| Dec 2020 | $396.23M(+3.3%) | $396.23M(+1.4%) |
| Sep 2020 | - | $390.81M(+8.5%) |
| Jun 2020 | - | $360.05M(+3.7%) |
| Mar 2020 | - | $347.31M(-9.5%) |
| Dec 2019 | $383.60M(-1.9%) | $383.60M(+4.3%) |
| Sep 2019 | - | $367.86M(-0.7%) |
| Jun 2019 | - | $370.49M(-3.0%) |
| Mar 2019 | - | $381.96M(-2.3%) |
| Dec 2018 | $390.91M(+72.0%) | $390.91M(-1.6%) |
| Sep 2018 | - | $397.12M(+95.5%) |
| Jun 2018 | - | $203.16M(+0.9%) |
| Mar 2018 | - | $201.32M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $227.21M(+4.5%) | $227.21M(+5.2%) |
| Sep 2017 | - | $215.99M(+2.2%) |
| Jun 2017 | - | $211.30M(+0.9%) |
| Mar 2017 | - | $209.45M(-3.7%) |
| Dec 2016 | $217.51M(+2.5%) | $217.51M(-3.3%) |
| Sep 2016 | - | $224.82M(+2.4%) |
| Jun 2016 | - | $219.60M(+16.9%) |
| Mar 2016 | - | $187.87M(-11.5%) |
| Dec 2015 | $212.29M(+22.9%) | $212.29M(-3.8%) |
| Sep 2015 | - | $220.62M(-19.6%) |
| Jun 2015 | - | $274.36M(+10.9%) |
| Mar 2015 | - | $247.42M(+43.2%) |
| Dec 2014 | $172.72M(+330.0%) | $172.72M(+10.6%) |
| Sep 2014 | - | $156.12M(+1.1%) |
| Jun 2014 | - | $154.47M(+19.3%) |
| Mar 2014 | - | $129.44M(+222.3%) |
| Dec 2013 | $40.17M(+592.6%) | $40.17M(+47.8%) |
| Sep 2013 | - | $27.17M(+144.1%) |
| Jun 2013 | - | $11.13M(+36.2%) |
| Mar 2013 | - | $8.17M(>+9900.0%) |
| Dec 2012 | $5.80M(+8555.4%) | - |
| Nov 2012 | - | $68.70K(+1.0%) |
| Aug 2012 | - | $68.00K(+0.7%) |
| May 2012 | - | $67.50K(+0.7%) |
| Feb 2012 | - | $67.00K(+2.0%) |
| Feb 2012 | $67.00K(+4.4%) | - |
| Nov 2011 | - | $65.70K(+0.8%) |
| Aug 2011 | - | $65.20K(+1.6%) |
| Feb 2011 | $64.20K | $64.20K |
FAQ
- What is Travere Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Travere Therapeutics?
- What is Travere Therapeutics annual total liabilities year-on-year change?
- What is Travere Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Travere Therapeutics?
- What is Travere Therapeutics quarterly total liabilities year-on-year change?
What is Travere Therapeutics annual total liabilities?
The current annual total liabilities of TVTX is $535.05M
What is the all time high annual total liabilities for Travere Therapeutics?
Travere Therapeutics all-time high annual total liabilities is $629.73M
What is Travere Therapeutics annual total liabilities year-on-year change?
Over the past year, TVTX annual total liabilities has changed by -$53.05M (-9.02%)
What is Travere Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TVTX is $515.98M
What is the all time high quarterly total liabilities for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total liabilities is $629.73M
What is Travere Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TVTX quarterly total liabilities has changed by -$73.50M (-12.47%)